Home > National Drug Code (NDC) > CARBIDOPA AND LEVODOPA

CARBIDOPA AND LEVODOPA - 16729-078-16 - (Carbidopa and Levodopa)

Alphabetical Index


Drug Information of CARBIDOPA AND LEVODOPA

Product NDC: 16729-078
Proprietary Name: CARBIDOPA AND LEVODOPA
Non Proprietary Name: Carbidopa and Levodopa
Active Ingredient(s): 25; 100    mg/1; mg/1 & nbsp;   Carbidopa and Levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of CARBIDOPA AND LEVODOPA

Product NDC: 16729-078
Labeler Name: Accord Healthcare, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA202323
Marketing Category: ANDA
Start Marketing Date: 20130509

Package Information of CARBIDOPA AND LEVODOPA

Package NDC: 16729-078-16
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-078-16)

NDC Information of CARBIDOPA AND LEVODOPA

NDC Code 16729-078-16
Proprietary Name CARBIDOPA AND LEVODOPA
Package Description 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-078-16)
Product NDC 16729-078
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carbidopa and Levodopa
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20130509
Marketing Category Name ANDA
Labeler Name Accord Healthcare, Inc.
Substance Name CARBIDOPA; LEVODOPA
Strength Number 25; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of CARBIDOPA AND LEVODOPA


General Information